Conference Coverage

New assay may be a game changer in invasive candidiasis

Publish date: September 22, 2015

 

EXPERT ANALYSIS FROM ICAAC 2015

References

Dr. Pappas reported receiving research grants from and serving as an advisor to T2 Biosystems, which markets the assay. He has also received research support from Astellas, Gilead, and Merck.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Smoother orthopedic implants may minimize bacterial adherence
MDedge Internal Medicine
Prolonged sepsis increased inpatient mortality risk
MDedge Internal Medicine
Cefazolin outperforms nafcillin for staphylococcal bacteremia
MDedge Internal Medicine
Underweight patients showed greater mortality with gram-negative bacteremia
MDedge Internal Medicine
Delayed treatment associated with higher mortality from VRE bloodstream infections
MDedge Internal Medicine
Community hospitals harness rapid testing to slash bacteremia mortality
MDedge Internal Medicine
Septicemia due to ‘ESKAPE’ pathogens rose between 2008 and 2012
MDedge Internal Medicine
Diabetic foot ulcer: Early closure post debridement best
MDedge Internal Medicine
Send patients reminders for flu vaccines, study says
MDedge Internal Medicine
ICU care improves survival without raising costs
MDedge Internal Medicine